Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bio Cel is a topical botanical lipid-based occlusive developed by Venus Concept for use as a post-treatment adjuvant following aesthetic skin procedures. It is specifically formulated to be applied after treatments that compromise the skin barrier, such as fractional radiofrequency ablation (e.g., Venus Viva). Bio Cel functions as a physical skin protectant, creating a barrier that prevents transepidermal water loss (TEWL) and shields the healing tissue from environmental irritants. In clinical settings, it is often evaluated as part of a combination regimen with a growth factor-rich serum (such as the SCR Complex) to improve patient tolerability, reduce downtime, and facilitate the natural repair process of the skin following resurfacing procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bio Cel.